Eastgate Biotech Corp Stock Working Capital
| ETBIDelisted Stock | USD 0 0.00 0.00% |
Eastgate Biotech Corp fundamentals help investors to digest information that contributes to Eastgate Biotech's financial success or failures. It also enables traders to predict the movement of Eastgate Stock. The fundamental analysis module provides a way to measure Eastgate Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eastgate Biotech stock.
Eastgate |
Eastgate Biotech Corp Company Working Capital Analysis
Eastgate Biotech's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Eastgate Biotech Working Capital | (1.94 M) |
Most of Eastgate Biotech's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eastgate Biotech Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionAccording to the company's disclosures, Eastgate Biotech Corp has a Working Capital of (1.94 Million). This is 100.46% lower than that of the Healthcare sector and significantly lower than that of the Pharmaceuticals industry. The working capital for all United States stocks is 100.13% higher than that of the company.
Eastgate Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eastgate Biotech's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Eastgate Biotech could also be used in its relative valuation, which is a method of valuing Eastgate Biotech by comparing valuation metrics of similar companies.Eastgate Biotech is currently under evaluation in working capital category among its peers.
Eastgate Fundamentals
| Operating Margin | (74.40) % | |||
| Current Valuation | 18.92 M | |||
| Shares Outstanding | 2.06 B | |||
| Price To Earning | (0.10) X | |||
| Price To Sales | 1.49 X | |||
| EBITDA | (3.55 M) | |||
| Net Income | (2.98 M) | |||
| Cash And Equivalents | 4.91 K | |||
| Total Debt | 1.67 M | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (389.48 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | -3039.35 | |||
| Market Capitalization | 205.75 K | |||
| Retained Earnings | (14.63 M) | |||
| Working Capital | (1.94 M) | |||
| Current Asset | 167 K | |||
| Current Liabilities | 2.11 M |
About Eastgate Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eastgate Biotech Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eastgate Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eastgate Biotech Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Eastgate Stock
If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |